200 related articles for article (PubMed ID: 22526518)
1. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells.
Vollbrecht T; Stirner R; Tufman A; Roider J; Huber RM; Bogner JR; Lechner A; Bourquin C; Draenert R
AIDS; 2012 Jul; 26(12):F31-7. PubMed ID: 22526518
[TBL] [Abstract][Full Text] [Related]
2. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.
Vollbrecht T; Brackmann H; Henrich N; Roeling J; Seybold U; Bogner JR; Goebel FD; Draenert R
J Med Virol; 2010 Mar; 82(3):358-70. PubMed ID: 20087935
[TBL] [Abstract][Full Text] [Related]
3. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
4. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
5. T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.
Downey JS; Attaf M; Moyle G; Gazzard B; Gotch F; Imami N
AIDS; 2011 Oct; 25(16):1981-6. PubMed ID: 21811141
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
[TBL] [Abstract][Full Text] [Related]
7. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells generated during cytomegalovirus in vitro stimulation of mononuclear cells from HIV-infected individuals on HAART correlate with decreased lymphocyte proliferation.
Jesser RD; Li S; Weinberg A
Virology; 2006 Sep; 352(2):408-17. PubMed ID: 16782163
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
10. Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.
López M; Soriano V; Peris-Pertusa A; Rallón N; Restrepo C; Benito JM
AIDS Res Hum Retroviruses; 2011 Feb; 27(2):157-65. PubMed ID: 20964478
[TBL] [Abstract][Full Text] [Related]
11. Characterization of CD8+ T lymphocytes in chronic HIV-1 subtype A infection in Rwandan women.
Jiang Y; Karita E; Castor D; Jolly PE
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51 Suppl():OL737-43. PubMed ID: 16171573
[TBL] [Abstract][Full Text] [Related]
12. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
Piriou ER; van Dort K; Nanlohy NM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2005 Mar; 35(3):796-805. PubMed ID: 15724243
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
14. Treatment Intensification in HIV-Infected Patients Is Associated With Reduced Frequencies of Regulatory T Cells.
Grützner EM; Hoffmann T; Wolf E; Gersbacher E; Neizert A; Stirner R; Pauli R; Ulmer A; Brust J; Bogner JR; Jaeger H; Draenert R
Front Immunol; 2018; 9():811. PubMed ID: 29760693
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of P-glycoprotein in peripheral blood CD8+ T lymphocytes from HIV-1-infected patients on antiretroviral therapy.
Zhang JC; Xie F; Yu XH; Deng ZY; Wang Y; Liang P; Sun L; Zhang FX
Int J Mol Med; 2014 Feb; 33(2):431-40. PubMed ID: 24337436
[TBL] [Abstract][Full Text] [Related]
16. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of proliferative responses to HIV-1 antigen in chronically HIV-infected patients under antiretroviral therapy.
Mohm JM; Rump JA; Schulte-Mönting J; Schneider J
J Clin Virol; 2004 Jul; 30(3):239-42. PubMed ID: 15135742
[TBL] [Abstract][Full Text] [Related]
18. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent mycobacterium tuberculosis infection suppresses T-cell function.
du Plessis N; Loebenberg L; Kriel M; von Groote-Bidlingmaier F; Ribechini E; Loxton AG; van Helden PD; Lutz MB; Walzl G
Am J Respir Crit Care Med; 2013 Sep; 188(6):724-32. PubMed ID: 23885784
[TBL] [Abstract][Full Text] [Related]
19. HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.
Garg A; Spector SA
J Infect Dis; 2014 Feb; 209(3):441-51. PubMed ID: 23999600
[TBL] [Abstract][Full Text] [Related]
20. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.
Heuvers ME; Muskens F; Bezemer K; Lambers M; Dingemans AC; Groen HJM; Smit EF; Hoogsteden HC; Hegmans JPJJ; Aerts JGJV
Lung Cancer; 2013 Sep; 81(3):468-474. PubMed ID: 23850196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
